Patents Assigned to Third Harmonic Bio, Inc.
  • Crystalline forms of a selective c-kit kinase inhibitor
    Patent number: 11767319
    Abstract: The present disclosure relates generally to various forms and compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: September 26, 2023
    Assignee: Third Harmonic Bio, Inc.
    Inventors: Gregg F. Keaney, Leonard Walter Rozamus, Jr., Jonathan James Loughrey, Jaclyn Raeburn, Yuxiang Song
  • Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same
    Patent number: 11744823
    Abstract: The present disclosure relates generally to pharmaceutical compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: September 5, 2023
    Assignee: Third Harmonic Bio, Inc.
    Inventors: Gregg F. Keaney, Elizabeth Kwong
  • CRYSTALLINE FORMS OF A SELECTIVE C-KIT KINASE INHIBITOR
    Publication number: 20220056026
    Abstract: The present disclosure relates generally to various forms and compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
    Type: Application
    Filed: July 15, 2021
    Publication date: February 24, 2022
    Applicant: Third Harmonic Bio, Inc.
    Inventors: Gregg F. Keaney, Leonard Walter Rozamus, JR., Jonathan James Loughrey, Jaclyn Raeburn, Yuxiang Song